Influence of Transfusions on Perioperative and Long-Term Outcome in Patients Following Hepatic Resection for Colorectal Metastases

Annals of Surgery

Volumn 237, Issue 6, 2003, Pages 860-870

  Kooby, David A ^a   Stockman, Jennifer ^a   Ben Porat, Leah ^a   Gonen, Mithat ^a   Jarnagin, William R ^a   Dematteo, Ronald P ^a   Tuorto, Scott ^a   Wuest, David ^a   Blumgart, Leslie H ^a   Fong, Yuman ^a,b   Bolton, John S ^b   Choti, Michael A ^b   Clary, Bryan ^b   Baisden, Clinton E ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Department of Surgery ^*

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD STORAGE; BLOOD TRANSFUSION; CANCER SURGERY; COLORECTAL CANCER; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LENGTH OF STAY; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PATIENT REFERRAL; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SURGICAL MORTALITY; SURVIVAL TIME; TREATMENT OUTCOME; VISCERAL METASTASIS; ARTICLE; COLORECTAL TUMOR; LIVER TUMOR; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; SURVIVAL;

BLOOD TRANSFUSION; COLORECTAL NEOPLASMS; FEMALE; HEPATECTOMY; HUMANS; LENGTH OF STAY; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037775811     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-200306000-00015     Document Type: Article

References (73)

1. Gascon P, Zoumbos NC, Young NS. Immunological abnormalities in patients receiving multiple blood transfusions. Ann Intern Med. 1984; 100:173-177.
2. Kaplan J, Sarnaik S, Gitlin J, et al. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood. 1984;64:308-310.
3. Peters WR, Fry RD, Fleshman JW, et al. Multiple blood transfusions reduce the recurrence rate of Crohn's disease. Dis Colon Rectum. 1989;32:749-753.
4. Ghio M, Contini P, Mazzei C, et al. Soluble HLA class I, HLA class II, and Fas ligand in blood components: A possible key to explain the immunomodulatory effects of allogeneic blood transfusions. Blood. 1999;93:1770-1777.
5. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrence rate. Lancet. 1982;2:662.
6. Foster RS, Costanza MC, Foster JC, et al. Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer. 1985;55:1195-1201.
7. Parrott NR, Lennard TWJ, Proud G, et al. Perioperative blood transfusion and recurrence of colorectal cancer. Br J Surg. 1986;73:505.
8. Tartter PI. The association of perioperative blood transfusion with colorectal cancer recurrence. Ann Surg. 1992;216:633-638.
9. Weiden PL, Bean MA, Schultz P. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer. 1987;60: 870-874.
10. Tartter PI, Burrows L, Kirschner P. Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset No) non-oat cell lung cancer. J Thorac Cardiovasc Surg. 1984;88:659-662.
11. Hyman NH, Foster RS, DeMeules JE, et al. Blood transfusions and survival after lung cancer resection. Am J Surg. 1985;149:502-507.
12. Moores DWO, Piantadosi S, Mckneally MF. Effect of perioperative blood transfusion on outcome in patients with surgically resected lung cancer. Ann Thorac Surg. 1989;47:346-351.
13. Little AG, Wu HS, Ferguson MK, et al. Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer. Am J Surg. 1990;160:630-633.
14. Keller SM, Groshen S, Martini N, et al. Blood transfusion and lung cancer recurrence. Cancer. 1988;62:606-610.
15. Nowak MM, Ponsky JL. Blood transfusion and disease-free survival in carcinoma of the breast. J Surg Oncol. 1984;27:124-130.
16. Foster RS, Foster JC, Costanza MC. Blood transfusions and survival after surgery for breast cancer. Arch Surg. 1984;119:1138-1140.
17. Voogt PJ, Vandevelde CJH, Brand A, et al. Perioperative blood transfusion and cancer prognosis: Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer. 1987; 59:836-843.
18. Manyonda IT, Shaw DE, Foulkes A, et al. Renal cell carcinoma: blood transfusion and survival. Br Med J. 1986;293:537-538.
19. Fong Y, Karpeh M, Mayer K, et al. Association of perioperative transfusions with poor outcome in resection of gastric adenocarcinoma. Am J Surg. 1994;167:256-260.
20. Sugezawa A, Kaibara N, Sumi K, et al. Blood transfusion and the prognosis of patients with gastric cancer. J Surg Oncol. 1989;42:113-116.
21. Kampschoer GHM, Maruyama K, Kinoshita T, et al. The effects of blood transfusion on the prognosis of patients with gastric cancer. World J Surg. 1989;13:637-643.
22. Moriguchi S, Maehara Y, Akazawa K, et al. Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer. Cancer. 1990;66:2331-2335.
23. Kaneda M, Horimi T, Ninomiya M, et al. Adverse affect of blood transfusions on survival of patients with gastric cancer. Transfusion (Paris). 1987;27:375-377.
24. Rosenberg SA, Seipp CA, White DE, et al. Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities. J Clin Oncol. 1985;3:698-709.
25. Francis DM. Relationship between blood transfusion and tumour behaviour. Br J Surg. 1991;78:1420-1428.
26. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion (Paris). 1996;36:175-186.
27. Nielsen HJ. Detrimental effects of perioperative blood transfusion. Br J Surg. 1995;82:582-587.
28. McAlister FA, Clark HD, Wells PS, et al. Perioperative allogeneic blood transfusion does not cause adverse sequelae in patients with cancer: a meta-analysis of unconfounded studies. Br J Surg. 1998;85: 171-178.
29. Vamvakas E, Moore SB. Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion (Paris). 1993;33:754-765.
30. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion (Paris). 1995;35:760-768.
31. Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg. 1993;80:427-432.
32. Duffy G, Neal KR. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfus Med. 1996;6:325-328.
33. Scheele J, Stang R, Altendorf-Hofmann A, et al. Resection of colorectal liver metastases. World J Surg. 1995;19:59-71.
34. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254-1262.
35. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938-946.
36. Belghiti J, Noun R, Zante E, et al. Portal triad clamping or hepatic vascular exclusion for major liver resection. A controlled study. Ann Surg. 1996;224:155-161.
37. Man K, Fan ST, Ng IO, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg. 1997;226:704-711.
38. Melendez JA, Arslan V, Fischer ME, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg. 1998;187:620-625.
39. Chan AC, Blumgart LH, Wuest DL, et al. Use of preoperative autologous blood donation in liver resections for colorectal metastases. Am J Surg. 1998;175:461-465.
40. Johnson LB, Plotkin JS, Kuo PC. Reduced transfusion requirements during major hepatic resection with use of intraoperative isovolemic hemodilution. Am J Surg. 1998;176:608-611.
41. Stephenson KR, Steinberg SM, Hughes KS, et al. Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg. 1988;208:679-687.
42. Doci R, Gennari L, Bignami P, et al. Morbidity and mortality after hepatic resection of metastases from colorectal cancer. Br J Surg. 1995;82:377-381.
43. Younes RN, Rogatko A, Brennan MF. The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg. 1991;214:107-113.
44. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:493-504.
45. Jarnagin WR, Bach AM, Winston CB, et al. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease? J Am Coll Surg. 2001;19:577-583.
46. Jarnagin WR, Conlon K, Bodniewicz J, et al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer. 2001:91:1121-1128.
47. Goldsmith N, Woodburne R. The surgical anatomy pertaining to liver resection. Surg Gynecol Obstet. 1957;105:310-318.
48. Couinaud C. Etudes anatomique et chirurgales. Paris: Mason. 1954.
49. Martin RC, Brennan MF, Jaques DP. Quality of complication reporting in the surgical literature. Ann Surg 2002;235:803-813.
50. Therneau TM, Grambsch PM. Modeling Survival Data. New York: Springer, 2001.
51. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318.
52. Makuuchi M, Takayama T, Gunven P, et al. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg. 1989;13:644-648.
53. Itasaka H, Yamamoto K, Taketomi A, et al. Influence of blood transfusion on postoperative long-term liver function in patients with hepatocellular carcinoma. Hepato-Gastroenterology. 1995;42:465-468.
54. Matsumata T, Ikeda Y, Hayashi H, et al. The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma. Cancer. 1993;72:1866-1871.
55. Kwon AH, Matsui Y, Kamiyama Y. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival. Cancer. 2001;91:771-778.
56. Fujimoto J, Okamoto E. Yamanaka N, et al. Adverse effect of perioperative blood transfusions on survival after hepatic resection for hepatocellular carcinoma. Hepato-Gastroenterology. 1997;44:1390-1396.
57. Asahara T, Katayama K, Itamoto T, et al. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma. World J Surg. 1999;23:676-680.
58. Yamamoto J, Kosuge T, Takayama T, et al. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery. 1994;115:303-309.
59. Tadros T, Wobbes T, Hendriks T. Blood transfusion impairs the healing of experimental intestinal anastomoses. Ann Surg. 1992;215: 276-281.
60. Tadros T, Wobbes T, Hendriks T. Opposite effects of interleukin-2 on normal and transfusion-suppressed heating of experimental intestinal anastomoses. Ann Surg. 1993;218:800-808.
61. van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation. 1998;97:562-568.
62. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med. 1998;122:145-151.
63. Bellantone R, Sitges-Serra A, Bossola M, et al. Transfusion timing and postoperative septic complications after gastric cancer surgery: a retrospective study of 179 consecutive patients. Arch Surg. 1998;133: 988-992.
64. Kinoshita Y, Udagawa H, Tsutsumi K, et al. Usefulness of autologous blood transfusion for avoiding allogenic transfusion and infectious complications after esophageal cancer resection. Surgery. 2000;127: 185-192.
65. Mynster T, Christensen IJ, Moesgaard F, et al. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Danish RANX05 Colorectal Cancer Study Group. Br J Surg. 2000;87:1553-1562.
66. Alfieri S, Carriero C, Caprino P, et al. Avoiding early postoperative complications in liver surgery. A multivariate analysis of 254 patients consecutively observed. Digestive Liver Dis. 2001;33:341-346.
67. Cole DJ, Ferguson CM. Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg. 1992;58:88-91.
68. Opelz G, Terasaki PI. Prolongation effect of blood transfusions on kidney graft survival. Transplantation. 1976;22:380-383.
69. Adoute BG. Autotransfusion. Using Your Own Blood. New York: Springer-Verlag, 1991.
70. Meryman HT, Hornblower M. The preparation of red cells depleted of leukocytes: review and evaluation. Tronsfusion (Paris). 1986;26:101-106.
71. Snyder EL. Prevention of HLA alloimmunization: role of leukocyte depletion and UV-B irradiation. Yale J Biol Med. 1990;63:419-427.
72. Huggins CE, Russell PS, Winn HJ, et al. Frozen blood in transplant patients: hepatitis and HL-A isosensitization. Transplant Proc. 1973; 5:809-812.
73. Karpoff HM, Tung C, Ng B, et al. Interferon gamma protects against hepatic tumor growth in rats by increasing Kupffer cell tumoricidal activity. Hepatology. 1996;24:374-379.